HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner
Authors:
- 23 September 2010
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 1 (6) , 1011-1016
Abstract
Epithelial to mesenchymal transition (EMT) is induced by transforming growth factor-β1 (TGF-β1) and is a crucial event for cancer cells to acquire invasive and metastatic phenotypes. However, the signals that induce EMT in cancer cells have yet to be adequately defined. In this study, a proteomic investigation was performed to understand the signaling pathway of the EMT of lung cancer using two-dimensional difference gel electrophoresis (2D-DIGE) and mass spectrometry. The protein expression profiles of A549 were compared to those of A549 cells treated with TGF-β1. Of more than 2,000 protein spots shown by 2D-DIGE, 53 were found to be up- or down-regulated upon induction with TGF-β1. In the 53 protein spots, the protein level of heat shock protein (HSP) 27 was found to increase significantly. HSP27 protein was higher in two different lung cancer cell lines, demonstrating the EMT phenomenon with TGF-β1. Notably, the silencing of HSP27 enhanced spindle integration, resulting in an additive effect with TGF-β1-induced EMT. Furthermore, the TGF-β1-induced HSP27 increase was not affected by the suppression of Smad2 and Smad3 in A549 cells. These results suggest that HSP27 was involved in TGF-β1-induced EMT in a Smad-independent manner in lung cancer cells and may provide an effective clinical strategy in lung cancer patients whose tumors are dependent on TGF-β1-induced EMT.Keywords
This publication has 27 references indexed in Scilit:
- MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokersProceedings of the National Academy of Sciences, 2009
- A Gene Expression Signature Associated with “K-Ras Addiction” Reveals Regulators of EMT and Tumor Cell SurvivalCancer Cell, 2009
- Thyroid Transcription Factor-1 Inhibits Transforming Growth Factor-β–Mediated Epithelial-to-Mesenchymal Transition in Lung Adenocarcinoma CellsCancer Research, 2009
- Use of a Cytokine Gene Expression Signature in Lung Adenocarcinoma and the Surrounding Tissue as a Prognostic ClassifierJNCI: Journal of the National Cancer Institute, 2007
- RETRACTED: A Genomic Strategy to Refine Prognosis in Early-Stage Non–Small-Cell Lung CancerNew England Journal of Medicine, 2006
- Molecular requirements for epithelial–mesenchymal transition during tumor progressionCurrent Opinion in Cell Biology, 2005
- Epithelial–mesenchymal transitions in development and pathologiesCurrent Opinion in Cell Biology, 2003
- Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasisNature Reviews Molecular Cell Biology, 2003
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- Epithelial–mesenchymal transitions in tumour progressionNature Reviews Cancer, 2002